Autobio Diagnostics Statistics

Total Valuation

Autobio Diagnostics has a market cap or net worth of CNY 24.03 billion. The enterprise value is 23.87 billion.

Market Cap	24.03B
Enterprise Value	23.87B

Important Dates

The next estimated earnings date is Friday, April 18, 2025.

Earnings Date	Apr 18, 2025
Ex-Dividend Date	n/a

Share Statistics

Autobio Diagnostics has 572.12 million shares outstanding. The number of shares has decreased by -0.59% in one year.

Current Share Class	n/a
Shares Outstanding	572.12M
Shares Change (YoY)	-0.59%
Shares Change (QoQ)	+7.89%
Owned by Insiders (%)	0.24%
Owned by Institutions (%)	14.90%
Float	164.43M

Valuation Ratios

The trailing PE ratio is 19.09 and the forward PE ratio is 15.69. Autobio Diagnostics's PEG ratio is 1.47.

PE Ratio	19.09
Forward PE	15.69
PS Ratio	5.30
PB Ratio	2.86
P/TBV Ratio	2.97
P/FCF Ratio	33.85
P/OCF Ratio	n/a
PEG Ratio	1.47

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 13.78, with an EV/FCF ratio of 33.61.

EV / Earnings	18.75
EV / Sales	5.21
EV / EBITDA	13.78
EV / EBIT	18.85
EV / FCF	33.61

Financial Position

The company has a current ratio of 2.57, with a Debt / Equity ratio of 0.07.

Current Ratio	2.57
Quick Ratio	0.89
Debt / Equity	0.07
Debt / EBITDA	0.33
Debt / FCF	0.82
Interest Coverage	51.99

Financial Efficiency

Return on equity (ROE) is 15.18% and return on invested capital (ROIC) is 8.74%.

Return on Equity (ROE)	15.18%
Return on Assets (ROA)	7.05%
Return on Capital (ROIC)	8.74%
Revenue Per Employee	827,080
Profits Per Employee	229,769
Employee Count	5,539
Asset Turnover	0.41
Inventory Turnover	1.93

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -22.90% in the last 52 weeks. The beta is 0.00, so Autobio Diagnostics's price volatility has been lower than the market average.

Beta (5Y)	0.00
52-Week Price Change	-22.90%
50-Day Moving Average	45.31
200-Day Moving Average	47.17
Relative Strength Index (RSI)	33.74
Average Volume (20 Days)	3,042,506

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Autobio Diagnostics had revenue of CNY 4.58 billion and earned 1.27 billion in profits. Earnings per share was 2.20.

Revenue	4.58B
Gross Profit	2.96B
Operating Income	1.27B
Pretax Income	1.41B
Net Income	1.27B
EBITDA	1.72B
EBIT	1.27B
Earnings Per Share (EPS)	2.20

Full Income Statement

Balance Sheet

The company has 832.15 million in cash and 579.77 million in debt, giving a net cash position of 252.38 million or 0.44 per share.

Cash & Cash Equivalents	832.15M
Total Debt	579.77M
Net Cash	252.38M
Net Cash Per Share	0.44
Equity (Book Value)	8.49B
Book Value Per Share	14.69
Working Capital	3.75B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 1.47 billion and capital expenditures -757.58 million, giving a free cash flow of 710.13 million.

Operating Cash Flow	1.47B
Capital Expenditures	-757.58M
Free Cash Flow	710.13M
FCF Per Share	1.24

Full Cash Flow Statement

Margins

Gross margin is 64.69%, with operating and profit margins of 27.64% and 27.78%.

Gross Margin	64.69%
Operating Margin	27.64%
Pretax Margin	30.78%
Profit Margin	27.78%
EBITDA Margin	37.46%
EBIT Margin	27.64%
FCF Margin	15.50%

Dividends & Yields

This stock pays an annual dividend of 1.05, which amounts to a dividend yield of 2.50%.

Dividend Per Share	1.05
Dividend Yield	2.50%
Dividend Growth (YoY)	31.51%
Years of Dividend Growth	2
Payout Ratio	49.22%
Buyback Yield	0.59%
Shareholder Yield	3.10%
Earnings Yield	5.24%
FCF Yield	2.95%

Dividend Details

Stock Splits

The last stock split was on May 27, 2021. It was a forward split with a ratio of 1.3.

Last Split Date	May 27, 2021
Split Type	Forward
Split Ratio	1.3

Scores

Autobio Diagnostics has an Altman Z-Score of 7.64.

Altman Z-Score	7.64
Piotroski F-Score	n/a